Alnylam Pharmaceuticals Inc (ALNY) — Net Asset Quality Index
Alnylam Pharmaceuticals Inc (ALNY) has a Net Asset Quality Index of 15.9% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $4.97 Billion minus total liabilities of $4.18 Billion yields net assets of $789.18 Million. A higher index indicates a stronger, lower-leverage balance sheet. For live market cap and overall valuation, see how much is Alnylam Pharmaceuticals Inc worth.
Quality Index
Net Assets
Total Assets
Total Liabilities
Alnylam Pharmaceuticals Inc Net Asset Quality Index Over Time (2002–2025)
This chart shows how Alnylam Pharmaceuticals Inc's Net Asset Quality Index has evolved across 24 annual periods from 2002 to 2025. As of December 2025, the index stands at 15.9%, representing net assets of $789.18 Million against total assets of $4.97 Billion USD. See ALNY total equity for net asset value and shareholders' equity analysis.
Annual Net Asset Quality Index for Alnylam Pharmaceuticals Inc (2002–2025)
The table below presents the year-by-year Net Asset Quality Index for Alnylam Pharmaceuticals Inc from 2002 to 2025, covering 24 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check how strategically is Alnylam Pharmaceuticals Inc's equity deployed to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 15.9% | $789.18 Million | $4.97 Billion | $4.18 Billion | ▲ +14.3 pp |
| 2024 | 1.6% | $67.09 Million | $4.24 Billion | $4.17 Billion | ▲ +7.3 pp |
| 2023 | -5.8% | $-220.64 Million | $3.83 Billion | $4.05 Billion | ▼ -1.3 pp |
| 2022 | -4.5% | $-158.22 Million | $3.55 Billion | $3.70 Billion | ▼ -20.6 pp |
| 2021 | 16.1% | $588.20 Million | $3.64 Billion | $3.06 Billion | ▼ -13.7 pp |
| 2020 | 29.8% | $1.02 Billion | $3.41 Billion | $2.39 Billion | ▼ -30.2 pp |
| 2019 | 60.1% | $1.44 Billion | $2.40 Billion | $956.44 Million | ▼ -22.6 pp |
| 2018 | 82.7% | $1.30 Billion | $1.57 Billion | $272.84 Million | ▼ -5.9 pp |
| 2017 | 88.6% | $1.77 Billion | $1.99 Billion | $228.30 Million | ▲ +15.7 pp |
| 2016 | 72.9% | $920.22 Million | $1.26 Billion | $342.59 Million | ▼ -18.3 pp |
| 2015 | 91.2% | $1.26 Billion | $1.39 Billion | $121.80 Million | ▲ +4.5 pp |
| 2014 | 86.7% | $936.27 Million | $1.08 Billion | $143.33 Million | ▲ +22.4 pp |
| 2013 | 64.3% | $270.35 Million | $420.53 Million | $150.18 Million | ▲ +17.7 pp |
| 2012 | 46.6% | $134.05 Million | $287.52 Million | $153.47 Million | ▲ +4.8 pp |
| 2011 | 41.9% | $118.00 Million | $281.92 Million | $163.92 Million | ▲ +1.6 pp |
| 2010 | 40.2% | $158.23 Million | $393.26 Million | $235.03 Million | ▲ +3.3 pp |
| 2009 | 37.0% | $177.97 Million | $481.38 Million | $303.42 Million | ▲ +0.5 pp |
| 2008 | 36.4% | $202.12 Million | $554.68 Million | $352.55 Million | ▼ -3.9 pp |
| 2007 | 40.3% | $199.17 Million | $493.79 Million | $294.62 Million | ▼ -43.5 pp |
| 2006 | 83.8% | $201.17 Million | $240.01 Million | $38.83 Million | ▲ +21.0 pp |
| 2005 | 62.8% | $61.78 Million | $98.35 Million | $36.57 Million | ▼ -7.0 pp |
| 2004 | 69.8% | $46.14 Million | $66.11 Million | $19.96 Million | ▲ +145.7 pp |
| 2003 | -75.9% | $-26.71 Million | $35.18 Million | $61.89 Million | ▼ -47.1 pp |
| 2002 | -28.8% | $-4.65 Million | $16.11 Million | $20.76 Million | — |